About LA CaTS

News

Dr. Candida Rebello Publishes LA CaTS Pilot in Diabetes, Obesity & Metabolism

Released: Tuesday, October 08, 2019
Dr. Candida Rebello

Candida Rebello, PhD, Post-doctoral Researcher at Pennington Biomedical Research Center, recently published an article in the journal Diabetes, Obesity and Metabolism, est. audience 6.1 million. Dr. Rebello was awarded a LA CaTS Pilot Award in 2018 funded by Pennington Biomedical titled "Clinical Safety and Pharmacokinetic Evaluation of Naringenin: Single Dose Escalation Randomized Double Blind Controlled Trial".

Click HERE to see the article "Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial".

 

###

About the Louisiana Clinical and Translational Science (LA CaTS) Center
The LA CaTS Center is comprised of three primary collaborating institutions in the state, including LSU's Pennington Biomedical Research Center in Baton Rouge, LSU Health Sciences Center in New Orleans, and Tulane University School of Medicine in New Orleans – and also includes six research partners: LSU Health Sciences Center in Shreveport, Louisiana State University in Baton Rouge, and in New Orleans, Xavier University of Louisiana, Children’s Hospital, Ochsner Health System, Southeast Louisiana Veterans Health Care System, and University Medical Center.  The LA CaTS Center’s vision for Louisiana encompasses the strengths and capacities unique to each member institution and represents a unified, comprehensive approach for targeting prevention, care and research of chronic diseases in the underserved population.  The scholar program is supported in part by U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center.  For more information, please visit www.lacats.org.